Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Surg. Sep 27, 2019; 11(9): 365-372
Published online Sep 27, 2019. doi: 10.4240/wjgs.v11.i9.365
Table 1 Baseline characteristics of the study cohort, n (%)
Percutaneous
Laparoscopic
Open Surgical
P value
n = 347n = 248n = 107
Age0.64
18-3556 (16.1)33 (13.3)13 (12.1)
36-60175 (50.4)137 (55.2)55 (51.4)
60 +116 (33.4)78 (31.5)39 (36.4)
Sex0.15
Male220 (63.4)158 (63.7)66 (61.7)
Female126 (36.3)90 (36.3)41 (38.3)
Race0.53
White224 (64.6)169 (68.1)70 (65.4)
Black50 (14.4)28 (11.3)15 (14.0)
Hispanic39 (11.2)20 (8.1)14 (13.1)
Asian-Pacific Islander9 (2.6)3 (1.2)2 (1.9)
Other14 (4.0)13 (5.2)2 (1.9)
Admission type< 0.001
Emergency318 (53.4)212 (35.6)65 (10.9)
Non-emergency26 (25.0)36 (34.6)42 (40.4)
Hospital type< 0.001
Urban teaching280 (47.6)227 (38.6)81 (13.8)
Urban non-teaching58 (60.4)19 (19.8)19 (19.8)
Rural9 (50)2 (11.1)7 (38.9)
Primary payer0.42
Medicare111 (32.0)62 (25.0)35 (32.7)
Medicaid71 (20.5)57 (23.0)24 (22.4)
Private121 (34.9)103 (41.5)36 (33.6)
Other44 (12.7)26 (10.5)12 (11.2)
Pancreatitis type0.06
Acute164 (47.3)89 (35.9)35 (32.7)
Acute on chronic84 (24.2)71 (28.6)25 (23.4)
Chronic38 (11.0)36 (14.5)17 (15.9)
Charlson Comorbidity index0.77
0126 (36.3)103 (41.5)45 (42.1)
1-2189 (54.5)123 (49.6)56 (52.3)
3-430 (8.6)21 (8.5)6 (5.6)
≥ 52 (0.6)1 (0.4)0 (0.0)
Table 2 Specific comorbidities of the study cohort, n (%)
Percutaneous
Laparoscopic
Surgical
P value
n = 347n = 248n = 107
Acute myocardial infarction15 (4.3)8 (3.2)5 (4.7)0.74
Congestive heart failure31 (8.9)19 (7.7)4 (3.7)0.21
Peripheral vascular disease15 (4.3)7 (2.8)3 (2.8)0.56
Cerebrovascular disease6 (1.7)3 (1.2)1 (0.9)0.78
Dementia2 (0.6)3 (1.2)0 (0.0)0.42
Chronic obstructive pulmonary disease58 (16.7)43 (17.3)16 (15.0)0.86
Rheumatoid disease11 (3.2)3 (1.2)0 (0.0)0.07
Peptic ulcer disease10 (2.9)13 (5.2)3 (2.8)0.28
Mild liver disease52 (15.0)36 (14.5)9 (8.4)0.21
Diabetes without complications105 (30.3)61 (24.6)32 (29.9)0.29
Diabetes with complications12 (3.5)11 (4.4)5 (4.7)0.77
Hemiplegia or paraplegia3 (0.9)0 (0.0)0 (0.0)0.21
Renal disease33 (9.5)24 (9.7)4 (3.7)0.14
Cancer (any malignancy)15 (4.3)6 (2.4)4 (3.7)0.46
Moderate or severe liver disease10 (2.9)17 (6.9)7 (6.5)0.06
Metastatic solid tumour6 (1.7)2 (0.8)0 (0.0)0.28
AIDS/HIV2 (0.6)1 (0.4)0 (0.0)0.72
Table 3 Procedure related complications, n (%)
ComplicationsPercutaneous
Laparoscopic
Open surgical
P value
n = 347n = 248n = 107
Transfusion of RBC39 (11.2)7 (2.8)20 (18.7)< 0.001a
Transfusion of FFP4 (1.2)4 (1.6)4 (3.7)0.19
Transfusion of Platelet2 (0.6)0 (0.0)0 (0.0)0.36
Mechanical ventilation37 (10.7)18 (7.3)12 (11.2)0.31
Pulmonary embolism11 (3.2)5 (2.0)2 (1.9)0.60
Acute deep vein thrombosis3 (0.9)3 (1.2)0 (0.0)0.52
Acute renal failure84 (24.2)49 (19.8)12 (11.2)0.01a
Urinary tract infection34 (9.8)12 (4.8)2 (1.9)0.01a
Pneumonia21 (6.1)8 (3.2)6 (5.6)0.28
Sepsis109 (31.4)34 (13.7)23 (21.5)< 0.001a
Acute hepatic failure5 (1.4)6 (2.4)1 (0.9)0.53
Acute respiratory failure60 (17.3)24 (9.7)9 (8.4)0.01a
Exacerbation of heart failure19 (5.5)13 (5.2)2 (1.9)0.30
Cardiac arrest5 (1.4)3 (1.2)0 (0.0)0.47
Intraabdominal abscess34 (9.8)14 (5.6)8 (7.5)0.18
Table 4 Inpatient outcome of the study cohort, n (%)
Percutaneous
Laparoscopic
Surgical
P value
n = 347n = 248n = 107
Length of stay, median97110.009a
Total charge, mean1842401210081653780.03a
Disposition, home166 (49.4)173 (70.6)68 (64.8)< 0.001a
Inpatient mortality11 (3.2)3 (1.2)2 (1.9)0.28
Table 5 Multivariable regression of length of stay and total charge
Standardized coefficient for length of stayP valueStandardized coefficient for total chargeP value
Type of pancreatitis
Acute pancreatitisReferenceReferenceReferenceReference
Chronic pancreatitis-0.197< 0.001-0.172< 0.001
Acute on chronic pancreatitis-0.130< 0.001-0.1480.001
Hospital type
Urban teachingReferenceReferenceReferenceReference
Urban non-teaching-0.0540.190.0090.82
Rural-0.0440.291-0.0460.277
Drainage type
LaparoscopicReferenceReferenceReferenceReference
Non-laparoscopic0.1350.0010.1020.017